Aprea Therapeutics
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Total raised
€5.0M
€5,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2018-12
latest 2018-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood19
base rate 51% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series C | €5.0M | Janus Henderson Investors | View deal → |